Creatinine testing prior to gadolinium administration

Laboratory results should be checked for the most recent serum creatinine on ALL patients (by the technologist performing the study). For patients with the following risk factors, serum creatinine with calculation of eGFR should be performed within 6 weeks of the MRI study:

Age over 60 years History of “kidney disease” as an adult, including renal tumor or transplant Diabetes treated with insulin or other prescribed medications Hypertension (high blood pressure) requiring medication Multiple myeloma Solid organ transplant History of severe hepatic disease/liver transplant/pending liver transplant. For patients in this category only, it is recommended that the patient's GFR assessment be nearly contemporaneous with the MR examination for which the gadolinium is to be administered.